Lagercrantz - Broad-Based Strength
2022-05-20 09:45:00
Redeye retains its positive take on Lagercrantz following a solid Q4 report showing strong growth and highlighting the group’s pricing power. Lagercrantz’s valuation multiples are at their lowest since mid-2020 which we, combined with its strong operations, find attractive.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/